A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

Medical Device Industry and The Role of the FDA in the United States of America During the Covid-19 Pandemic

Dr Archana Nagajaran Is A Freelance Scientist At Kolabtree.By: Dr. Archana Nagarajan
Freelance Scientist at Kolabtree

The COVID-19 pandemic has brought the world to a standstill and hit most countries very hard. The USA is in the eye of the storm and the virus has caused immense loss of life and health and has put enormous strain on the healthcare professionals (HCPs) and the hospitals.

There has been a shortage of ventilators, Personal Protective Equipment (PPEs), and test kits. All of these are medical devices. Thus, the medical device industry finds itself in the center of the gargantuan efforts needed to get us through this pandemic. The U.S. Food and Drug Administration (FDA) is the central regulatory body in the US that regulates the medical devices and combination products used for diagnosis and treatment of COVID-19- invitro-diagnostic (IVD) kits, PPEs, ventilators, surgical masks, etc. The FDA has come up with certain regulatory changes that now can ensure quick approval of these important, yet short-in-supply medical devices, reducing the time to market and thus, providing HCPs and also, other professionals with the required tools to fight this pandemic.

Emergency Use Authorization (EUA)

The FDA has issued Emergency Use Authorizations (EUAs) for various diagnostic, protective, and therapeutic medical devices to respond to COVID-19. EUAs were previously also issued during the Zika virus and Ebola virus outbreaks.

At the beginning of February 2020, FDA issued EUA for IVDs for detection/diagnosis of novel coronavirus (2019-nCoV) so that enough tests are available through the USA where the number of cases suddenly exploded.

The ventilator related EUA allows for automotive and other industrial manufacturers to start manufacturing ventilators provided that they are aware of the quality, safety, and performance standards specified by FDA. The templates for the application and further information are available on the FDA website.

However, EUA for these devices and equipment allow their use only during this pandemic and as soon as the pandemic is over, these products would need to meet the usual regulatory guidelines of FDA.

Suspension of on-site audits

FDA has decided to suspend its on-site domestic and international audits except for certain mission-critical inspections. These inspections will be identified on a case-by-case basis and will be conducted with appropriate safety measures. FDA has implemented some alternative approaches to the on-site audits. It is currently working with CDC on when and how to return to on-site audits.

Guidance documents

FDA has issued various guidance documents that describe the agency’s interpretation of a policy or regulatory issue with regards to COVID-19. The guidance documents are addressed to the manufacturers, laboratories or the FDA staff.

Frequently Asked Questions (FAQs)

FDA has a comprehensive list of FAQs that it regularly updates with regards to COVID-19 and medical devices.

Virtual Town Halls

Since the beginning of March, FDA has been regularly hosting Virtual Town Halls for the clinical laboratories and commercial manufacturers that have developed/developing molecular tests for diagnosis of SARS-CoV-2.  The main idea behind this town hall meeting is to discuss various technical challenges with respect to the development and validation of the various diagnostic tests that are being developed.

Though FDA was initially criticized for its slow response to the COVID-19 pandemic since then FDA had come up with various policy innovations and regulatory updates to ensure that the people of USA get timely access to new technology during these times where the quality, safety and performance of the devices, PPEs and diagnostic tests remain high. The FDA website has lots of resources that are pretty helpful for the manufacturers, laboratories, researchers, and HCPs to keep abreast of the latest information with regards to COVID-19.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Experts Views and Opinions

When it was first announced, Apple Vision Pro was widely heralded as the savior of the VR/XR dream. Would Apple do to the spatial computing market what it did to the mobile phone market in the late noughties? What is the reality now that the device is launched – what does it mean for the business world’s adoption and effective utilization of spatial computing, and more specifically for our customers who are focused on surgical education and medical device sales and adoption? Read on.
Chuck Serrin advises since the pandemic, there has been a rise in ordering everything to the home - from vitamins to prescription drugs - and the days of venturing to a brick-and-mortar store are declining. The pharmaceutical industry is no different. It too is evolving, and pharmacy-focused businesses must make sure their systems are updated to keep up with the changing times.
Shawn Luke is a technical marketing engineer at DigiKey. DigiKey is recognized as the global leader and continuous innovator in the cutting-edge commerce distribution of electronic components and automation products worldwide, providing more than 15.3 million components from over 2,900 quality name-brand manufacturers. Read what he has to say.

By using this website you agree to accept Medical Device News Magazine Privacy Policy